IP Verse

Arthropoda Repellent Composition - EP3763212

The patent EP3763212 was granted to Sanderstrothmann on Aug 18, 2021. The application was originally filed on Jul 11, 2019 under application number EP19185690A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3763212

SANDERSTROTHMANN
Application Number
EP19185690A
Filing Date
Jul 11, 2019
Status
Granted And Under Opposition
Jul 16, 2021
Grant Date
Aug 18, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

DAKEMMay 13, 2022CABINET NONYADMISSIBLE
DAKEMMay 13, 2022IPSILONADMISSIBLE

Patent Citations (16) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP2439188
DESCRIPTIONJPH03133906
DESCRIPTIONUS4474081
DESCRIPTIONUS4774082
DESCRIPTIONWO2004006674
DESCRIPTIONWO2017199145
DESCRIPTIONWO2018050211
OPPOSITIONBR102016004354
OPPOSITIONEP1738744
OPPOSITIONEP2969026
OPPOSITIONEP3763212
OPPOSITIONWO2017143421
SEARCHDE102005030016
SEARCHDE2942835
SEARCHEP3056189
SEARCHUS2008319015

Non-Patent Literature (NPL) Citations (9) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- LURIE et al., "Pharmacokinetics of insect repellent N,N-diethyl toluamide", Med. Parazitol., (19790000), vol. 47, page 72
DESCRIPTION- MEHR et al., "Laboratory Evaluation of Controlled-Release Insect Repellent Formulations", J. Am. Mosq. Control Assoc., (19850000), vol. 1, page 143
DESCRIPTION- REIFENRATH et al., "Evaporation and Skin penetration characteristics of mosquito repellent formulations", J. Am. Mosq. Control Assoc., (19890000), vol. 5, page 45, XP002914463
OPPOSITION- Lubrizol, "Safety Data Sheet Glucam(TM) P-20 Humectant", (20160219), pages 1 - 8, XP055925239
OPPOSITION- Lupi E, Et Al, "The efficacy of repellents against Aedes, Anopheles, Culex and Ixodes spp. - A literature review", Travel medicine and Infectious Disease, (20130101), vol. xx, pages 1 - 38, XP055925241
OPPOSITION- Sarunyoo Songkro et al, "Effects of Glucam P-20, Vanillin, and Fixolide on Mosquito Repellency of Citronella Oil Lotions", JOURNAL OF MEDICAL ENTOMOLOGY, US , (20120501), vol. 49, no. 3, doi:10.1603/ME11141, ISSN 0022-2585, pages 672 - 677, XP055627153
SEARCH- Anon., "Sicherheitsdatenblatt 1907/2006/EG -REACH (DE) Anti-Brumm Zecken Stopp/Anti-Tiques 82049", (20160617), pages 1 - 12, URL: https://www.bueromarkt-ag.de/bilder/produktdatenblaetter/47617.pdf, (20190927), XP055626971 [Y] 1-13 * pages 1-2 *
SEARCH- Stiftung Warentest, "Medikamente im Test - Insektenabwehrmittel - Repellentien - Stiftung Warentest", (20170316), pages 1 - 3, URL: https://www.test.de/medikamente/Medikamente-im-Test-insektenabwehrmittel-repellentien-2999827-0/, (20190927), XP055626982 [Y] 1-13 * page 1, lines 1-19 *
SEARCH- SARUNYOO SONGKRO ET AL, "Effects of Glucam P-20, Vanillin, and Fixolide on Mosquito Repellency of Citronella Oil Lotions", JOURNAL OF MEDICAL ENTOMOLOGY., US, (20120501), vol. 49, no. 3, doi:10.1603/ME11141, ISSN 0022-2585, pages 672 - 677, XP055627153 [Y] 1-13 * abstract * * page 672, column right, line 27 - page 673, column left, line 12; figure 1 * * tables 1, 3 * * page 676, column left, lines 24-29 *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents